Dr. Sujuan Ba has served as the President & CEO of the National Foundation for Cancer Research since 2019 and the founder & CEO of the Asian Fund for Cancer Research since 2005. Dr. Ba is a co-founder and a founding board member of the Global Coalition for Adaptive Research (GCAR), a non-profit organization pioneering the groundbreaking adaptive clinical trial platforms to deliver innovative therapies to patients faster. Dr. Sujuan Ba is also CEO & Co-founder of the AIM-HI Accelerator Fund, a non-profit organization focused on advancing oncology start-ups through venture and impact investments. She serves as a scientific advisor and a board member for more than half a dozen oncology start-ups.
Dr. Ba has led the establishment of NFCR’s annual Szent-Györgyi Prize for Progress in Cancer Research, an international prize recognizing outstanding scientific achievement in the war against cancer. She has served continuously as co-chair of the Prize Selection Committee since 2006. The prize has now grown into one of the premier cancer research awards in the world.
Dr. Ba has also led the establishment of AIM-HI Venture Competition in 2020, a first-of-its-kind program that provides investment, coaching, and networking opportunities to oncology start-ups worldwide. More than 400 early-stage oncology start-ups have gone through the rigorous review and judging process of the AIM-HI Venture Competition platform.
Dr. Ba has served on the Women in Science Committee of CRS (Control Release Society) since 2017. She is also a Member of Springboard’s Life Science Council, a group of experts worldwide in biotech, pharma, medical devices, and health IT who invest their “human capital” in Springboard’s pipeline of high-growth companies.
Dr. Ba was honored with the “2024 Pioneer in Medicine Award” by the World Brain Mapping Foundation and the Society for Brain Mapping and Therapeutics, which recognized her leadership and highlighted her pioneering spirit in the global fight against cancer. Dr. Ba received NBC4 WORKING 4 THE COMMUNITY Award in 2019, recognizing her outstanding achievements as a scientist, leader, and role model in the STEM fields. She was named one of the “Top 300 Women Leaders in Global Health” in 2015 by the Graduate Institute of International and Development Studies’ Global Health Programme. She was selected to receive the CRS WOMEN IN SCIENCES Award in 2011.
Dr. Ba received her BS in radiochemistry from Peking University and her Ph.D. in chemistry from the University of Pennsylvania.
